Immunomodulatory functions of FXR

Area of Science:

• Immunology
• Endocrinology
• Gastroenterology

Background:

• The Farnesoid-x-receptor (FXR) is a bile acid sensor crucial for regulating bile acid metabolism and innate immunity.
• FXR is expressed in key metabolic and immune organs, including the liver, intestine, adrenal glands, and immune cells like macrophages.
• FXR and GPBAR1 (G protein-coupled bile acid receptor 1) coordinate inter-organ communication, influencing the immune system and gut microbiota.

Purpose of the Study:

• To explore the role of FXR in innate immunity and its implications in liver and intestinal diseases.
• To investigate the potential of FXR agonism as a therapeutic strategy for inflammation-driven immune dysfunction.
• To clarify the clinical relevance of FXR-mediated mechanisms in FXR-related disorders.

Main Methods:

• Review of existing literature on FXR function in physiology and disease.
• Analysis of FXR expression patterns in various tissues and cell types.
• Examination of preclinical models demonstrating FXR agonism's effects on inflammation.

Main Results:

• FXR disruption leads to generalized inflammation and impaired bile acid metabolism.
• FXR agonism in preclinical models shows potential in mitigating inflammation and immune dysfunction.
• The precise clinical significance of these findings in human FXR-related disorders remains largely undefined.

Conclusions:

• FXR is a critical regulator of bile acid homeostasis and immune responses.
• FXR agonism presents a promising therapeutic avenue for inflammatory conditions affecting the liver and gut.
• Further clinical research is essential to validate the therapeutic benefits of targeting FXR in human diseases.